Key facts
- Sempre Health’s last known valuation is $90.8M (Sep 2023).
- It has raised $45.6M across 1 recorded rounds; the latest was Early Stage VC ($8.0M) in Aug 2018.
- Notable investors include FJ Labs, Alchemist Accelerator, Industry Ventures, Sterling Road, Social Capital — 13 tracked in total.
- Sempre Health has filed 1 Form D with the SEC, most recently Aug 2018 ($8.0M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Sempre Health
Funding rounds
1 roundsAbout Sempre Health
Developer of a behavior-based prescription savings platform designed for medication adherence and cost reduction. The company's platform delivers automated copay discounts and refill reminders via text message, requires no app or account creation, integrates with health plans and pharmacies, and allows eligible members to save when prescriptions are filled on time, enabling health insurers and patients to reduce overall healthcare costs through improved adherence.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2015
- Employees
- 32
- Website
- semprehealth.com/
- Ownership
- Privately Held (backing)
Sempre Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sempre Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sempre Health in its N-PORT filings yet. We sweep new filings monthly.